- Home
- CLLS vs STRS Comparison
CLLS vs STRS Comparison
Compare CLLS & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- STRS
- Stock Information
- Founded
- CLLS 1999
- STRS 1992
- Country
- CLLS France
- STRS United States
- Employees
- CLLS N/A
- STRS N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- STRS Homebuilding
- Sector
- CLLS Health Care
- STRS Real Estate
- Exchange
- CLLS Nasdaq
- STRS Nasdaq
- Market Cap
- CLLS 144.4M
- STRS 133.9M
- IPO Year
- CLLS 2007
- STRS N/A
- Fundamental
- Price
- CLLS $1.58
- STRS $19.39
- Analyst Decision
- CLLS Buy
- STRS
- Analyst Count
- CLLS 3
- STRS 0
- Target Price
- CLLS $7.00
- STRS N/A
- AVG Volume (30 Days)
- CLLS 79.4K
- STRS 6.7K
- Earning Date
- CLLS 05-27-2025
- STRS 05-13-2025
- Dividend Yield
- CLLS N/A
- STRS N/A
- EPS Growth
- CLLS N/A
- STRS N/A
- EPS
- CLLS N/A
- STRS 0.24
- Revenue
- CLLS $49,217,000.00
- STRS $54,183,000.00
- Revenue This Year
- CLLS $48.52
- STRS N/A
- Revenue Next Year
- CLLS $5.17
- STRS N/A
- P/E Ratio
- CLLS N/A
- STRS $84.17
- Revenue Growth
- CLLS 435.38
- STRS 213.74
- 52 Week Low
- CLLS $1.10
- STRS $15.41
- 52 Week High
- CLLS $3.32
- STRS $30.66
- Technical
- Relative Strength Index (RSI)
- CLLS 60.44
- STRS 59.23
- Support Level
- CLLS $1.46
- STRS $15.10
- Resistance Level
- CLLS $1.65
- STRS $20.50
- Average True Range (ATR)
- CLLS 0.08
- STRS 0.84
- MACD
- CLLS -0.00
- STRS 0.40
- Stochastic Oscillator
- CLLS 75.00
- STRS 79.44
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.